Skip to content

A clinical trial to improve quality of life in aged care

A cluster clinical trial in residential aged care facility (RACF) patients to determine whether care coordination is superior to usual care in reducing hospital transfer and improving resident quality of life.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000933954
Enrollment
200
Registered
2011-08-30
Start date
2012-06-11
Completion date
2014-03-05
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

People living in residential aged care facilities (RACF) are amongst the most vulnerable Australians. Their acute healthcare needs are great yet we do not know whether the current system of providing much of this care in hospitals meets their interests or those of the broader community. This trial will test a new model of caring for people in RACF, to determine whether it can reduce hospital utilisation and improve quality of life.

Interventions

A coordinated care planning intervention with three key components a. Comprehensive assessment which will incorporate an initial individual needs assessment focussing on current and likely future healthcare needs. The needs assessment will particularly focus on identifying patient preferences and goals (utilising informant perspectives where necessary) with respect to palliative care. It is anticipated the needs assessment will require at least two hour long sessions soon after enrolment. b. Ind

A coordinated care planning intervention with three key components a. Comprehensive assessment which will incorporate an initial individual needs assessment focussing on current and likely future healthcare needs. The needs assessment will particularly focus on identifying patient preferences and goals (utilising informant perspectives where necessary) with respect to palliative care. It is anticipated the needs assessment will require at least two hour long sessions soon after enrolment. b. Individualised care planning utilising six strategies that are most likely to impact on hospital transfer and quality of life. 1. Patient +/- family education regarding diagnosis and prognosis. A research nurse will provide clear simple language verbal and written information regarding illness and expected clinical course. 2. An advanced care plan incorporating preferences of the patient and family for the setting of limits, if any, on hospitalisation, interventions, and resuscitation. 3. A palliative care plan for management of current and anticipated future symptoms. 4. Primary care and assessment plan for the management of minor injury and illness tailored to the patient and RACF requirements. This may involve use of the patient’s regular general practitioner or other existing primary care services that augment general practice. 5. Clinical practice guideline package for the management of major injury and illness. Tailored guidelines will be provided to deal with common acute complications requiring hospitalisation. 6. Root cause analysis of all hospitalisations. We will use QI methodology to assess any hospitalisations in the intervention group and determine whether they were possibly avoidable and if so, what changes would be required to prevent a similar hospitalisation. Whilst it is impossible to be proscriptive about how much contact will be required for each patient in the intervention arm, there will be minimum weekly contact with the patient and facility to manage the care planning. c. Coordination of these strategies, and their systematic application, based on individual patient needs identified through comprehensive assessment. Each patient in the intervention arm will be assigned to a research nurse who will be directly responsible for providing key aspects of the intervention (including some primary care surveillance and service provision) and coordinate other aspects that require specialist and/or multidisciplinary involvement. From enrolment, patients will be exposed to the intervention for a minimum period of eighteen months unless they die or return to live in the community on a permanent basis.

Sponsors

University of Western Australia
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients will be eligible for inclusion if they are residents in a permanent high level care bed in an accredited RACF

Exclusion criteria

Patients will be excluded if they meet any of the following criteria 1. Not eligible for Medicare 2. Age < 65 years 3. Patient not expected to survive more than 60 days after entry to the facility 4. Patient already resident within a low care facility with a support package to manage them as a high care patient

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026